WallStreetZenWallStreetZen

NASDAQ: SONN
Sonnet Biotherapeutics Holdings Inc Stock

Open Broker Account
$1.47+0.04 (+2.8%)
Updated Sep 30, 2022
SONN Price
$1.47
Fair Value Price
$2.68
Market Cap
$6.36M
52 Week Low
$1.23
52 Week High
$10.22
P/E
-0.23x
P/B
8.32x
P/S
22.02x
PEG
N/A
Dividend Yield
N/A
Revenue
$770.82k
Earnings
-$29.24M
Gross Margin
100%
Operating Margin
-3,793.2%
Profit Margin
-3,793.2%
Debt to Equity
8.8
Operating Cash Flow
-$27M
Beta
1.06
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

SONN Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SONN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SONN ($1.47) is undervalued by 45.08% relative to our estimate of its Fair Value price of $2.68 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SONN ($1.47) is significantly undervalued by 45.08% relative to our estimate of its Fair Value price of $2.68 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
SONN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SONN due diligence checks available for Premium users.

Be the first to know about important SONN news, forecast changes, insider trades & much more!

SONN News

Valuation

SONN fair value

Fair Value of SONN stock based on Discounted Cash Flow (DCF)
Price
$1.47
Fair Value
$2.68
Undervalued by
45.08%
SONN ($1.47) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SONN ($1.47) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SONN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SONN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.23x
Industry
14.28x
Market
27.64x

SONN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
8.32x
Industry
4.39x
SONN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SONN's financial health

Profit margin

Revenue
$62.1k
Net Income
-$7.9M
Profit Margin
-12,690.3%
SONN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SONN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$7.5M
Liabilities
$6.7M
Debt to equity
8.8
SONN's short-term assets ($7.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SONN's short-term assets ($7.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SONN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
SONN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$7.8M
Investing
-$586.3k
Financing
$0.0
SONN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SONN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
SONN$6.36M+2.80%-0.23x8.32x
CELZ$6.19M-8.14%-0.12x0.27x
CFRX$6.61M-6.67%-0.14x0.51x
REVB$6.11M-4.40%-0.05x-3.32x
ENVB$6.65M-2.09%-0.04x0.30x

Sonnet Biotherapeutics Holdings Stock FAQ

What is Sonnet Biotherapeutics Holdings's quote symbol?

NASDAQ: SONN) Sonnet Biotherapeutics Holdings trades on the NASDAQ under the ticker symbol SONN. Sonnet Biotherapeutics Holdings stock quotes can also be displayed as NASDAQ: SONN.

If you're new to stock investing, here's how to buy Sonnet Biotherapeutics Holdings stock.

What is the 52 week high and low for Sonnet Biotherapeutics Holdings (NASDAQ: SONN)?

(NASDAQ: SONN) Sonnet Biotherapeutics Holdings's 52-week high was $10.22, and its 52-week low was $1.23. It is currently -85.62% from its 52-week high and 19.51% from its 52-week low.

How much is Sonnet Biotherapeutics Holdings stock worth today?

(NASDAQ: SONN) Sonnet Biotherapeutics Holdings currently has 4,327,707 outstanding shares. With Sonnet Biotherapeutics Holdings stock trading at $1.47 per share, the total value of Sonnet Biotherapeutics Holdings stock (market capitalization) is $6.36M.

Sonnet Biotherapeutics Holdings stock was originally listed at a price of $45,500.05 in Oct 31, 2006. If you had invested in Sonnet Biotherapeutics Holdings stock at $45,500.05, your return over the last 15 years would have been -100%, for an annualized return of -49.81% (not including any dividends or dividend reinvestments).

How much is Sonnet Biotherapeutics Holdings's stock price per share?

(NASDAQ: SONN) Sonnet Biotherapeutics Holdings stock price per share is $1.47 today (as of Sep 30, 2022).

What is Sonnet Biotherapeutics Holdings's Market Cap?

(NASDAQ: SONN) Sonnet Biotherapeutics Holdings's market cap is $6.36M, as of Oct 2, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Sonnet Biotherapeutics Holdings's market cap is calculated by multiplying SONN's current stock price of $1.47 by SONN's total outstanding shares of 4,327,707.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.